Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets

From US FDA

Glenmark Pharmaceuticals announced that its US subsidiary, Glenmark Generics Inc., has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1mg/5 mcg. Glenmark will commence distribution of the product immediately.

Powered by Capital Market - Live News